Use of the glutamate NMDA receptor antagonist PK-Merz in acute stroke.
Krivonos
O V
OV
Department of the Organization of Medical Care and Healthcare Development, Ministry of Health and Social Development of the Russian Federation, Moscow, Russia.
Amosova
N A
NA
Smolentseva
I G
IG
D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D020521:Stroke / Q000188:drug therapy* / Q000503:physiopathology
D016194:Receptors, N-Methyl-D-Aspartate; D000547:Amantadine
Stroke. 2001 Sep;32(9):2137-42
11546908
Stroke. 1998 Feb;29(2):535-42
9472902
Stroke. 2004 May;35(5):1197-202
15060319
Zh Nevrol Psikhiatr Im S S Korsakova. 2004;104(3):73-9
15071851
Stroke. 2003 Nov;34(11):2599-603
14563969
N Engl J Med. 2006 Feb 9;354(6):588-600
16467546
Stroke. 2000 Feb;31(2):347-54
10657404
J Neurosci. 2005 Mar 30;25(13):3312-22
15800186
Stroke. 2007 May;38(5):1655-711
17431204
Stroke. 2001 Jan;32(1):100-6
11136922
Stroke. 2002 Jun;33(6):1545-50
12052989
Stroke. 2002 Feb;33(2):449-55
11823651
Stroke. 2006 Apr;37(4):1129-36
16527996
Zh Nevrol Psikhiatr Im S S Korsakova. 2000;100(10):34-8
11081266
Stroke. 2001 Feb;32(2):466-72
11157184